Clinical trial
A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal…
NCT00385970 · Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group, Other · Unknown status
Key facts
| NCT number | NCT00385970 |
|---|---|
| Title | A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer |
| Official title | A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer |
| Lead sponsor | Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Tegafur-uracil (UFT), Calcium folinate (LV), Krestin (PSK) |
| Enrollment | 380 |
| Start date | Mar 1, 2006 |
| Primary completion | Apr 1, 2015 |
| Completion | Apr 1, 2015 |
| First posted | Oct 11, 2006 |
| Last update posted | Oct 26, 2012 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: